Kikuo Arakawa Selected Research

Coronary Stenosis (Coronary Artery Stenosis)

1/2002

Relation between type A behavior pattern and the extent of coronary atherosclerosis in Japanese women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kikuo Arakawa Research Topics

Disease

7	Hypertension (High Blood Pressure) 10/2012 - 09/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2012 - 03/2004
3	Coronary Disease (Coronary Heart Disease) 09/2006 - 06/2003
3	Hypercholesterolemia 01/2005 - 01/2002
2	Stroke (Strokes) 09/2006 - 06/2003
2	Diabetes Mellitus 01/2005 - 05/2004
2	Cerebral Infarction 01/2005 - 06/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2004 - 03/2004
1	Chronic Renal Insufficiency 01/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Essential Hypertension 01/2009
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2003
1	Emaciation 09/2003
1	Leukocytosis (Pleocytosis) 09/2003
1	Atrial Remodeling 06/2003
1	Atrial Fibrillation 06/2003
1	Fibrosis (Cirrhosis) 06/2003
1	Myocardial Infarction 01/2003
1	Infarction (Infarctions) 01/2003
1	Cardiomegaly (Heart Hypertrophy) 01/2003
1	Atherosclerosis 09/2002
1	Body Weight (Weight, Body) 09/2002
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2002

Drug/Important Bio-Agent (IBA)

5	CholesterolIBA 09/2006 - 09/2002
5	LipidsIBA 01/2005 - 09/2002
3	Angiotensin Receptor AntagonistsIBA 01/2013 - 07/2009
3	Olmesartan Medoxomil (Votum)FDA Link 07/2009 - 01/2006
3	Chymases (Chymase)IBA 09/2003 - 09/2002
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2013 - 10/2012
2	olmesartanIBA 10/2012 - 01/2009
2	SaltsIBA 03/2011 - 07/2006
2	HDL CholesterolIBA 01/2005 - 05/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2005 - 01/2002
2	Nifedipine (Adalat)FDA LinkGeneric 07/2004 - 03/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2004 - 03/2004
2	Angiotensin IIIBA 09/2003 - 01/2003
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2013
1	CalciumIBA 10/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011
1	azelnidipineIBA 01/2009
1	Pravastatin (Pravachol)FDA LinkGeneric 09/2006
1	candesartan cilexetil (Amias)FDA Link 01/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2004
1	HDL LipoproteinsIBA 05/2004
1	Valsartan (Vals)FDA Link 09/2003
1	candesartanIBA 06/2003
1	Type 1 Angiotensin ReceptorIBA 06/2003
1	Angiotensin II Type 1 Receptor BlockersIBA 06/2003
1	Butyric Acid (Butanoic Acid)IBA 01/2003
1	4- (1- (naphthylmethyl)benzimidazol- 2- ylthio)butanoic acidIBA 01/2003
1	LDL CholesterolIBA 09/2002
1	SUN-C 8257IBA 09/2002
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2002
1	Phenobarbital (Luminal)FDA Link 01/2002

Therapy/Procedure

1	Therapeutics 03/2004
1	Ligation 01/2003